Heren Health Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	393.6	394.46	429.76	345.45	450.78	442.4
Other Revenue	11.55	11.55	9.5	14.88	13.42	12.34
Revenue	405.15	406.01	439.25	360.33	464.2	454.74
Revenue Growth (YoY)	-3.79%	-7.57%	21.90%	-22.38%	2.08%	3.13%
Cost of Revenue	204.52	218.11	270.29	288.73	305.7	261.58
Gross Profit	200.63	187.9	168.96	71.6	158.5	193.16
Selling, General & Admin	67.94	62.49	78.98	80.99	66.03	84.43
Research & Development	58.74	52.52	53.81	54.05	53.83	44.18
Other Operating Expenses	-6.63	-1.66	-9.85	-5.17	-2.15	-4.73
Operating Expenses	149.56	158.23	142.82	169.16	135.15	157.65
Operating Income	51.07	29.67	26.14	-97.56	23.35	35.51
Interest Expense	-2.63	-4.27	-3.86	-3.49	-2.53	-2.77
Interest & Investment Income	8.46	10.6	15.33	11.7	13.76	6.69
Other Non Operating Income (Expenses)	-0.85	-0.82	2.3	-0.08	-0.21	-0.2
EBT Excluding Unusual Items	56.06	35.19	39.9	-89.43	34.37	39.23
Gain (Loss) on Sale of Investments	0.71	0.82	0.72	0.14	-	-
Gain (Loss) on Sale of Assets	-0.07	0.12	-0.1	-0.04	-0.04	-0.02
Asset Writedown	-12.99	-0.06	-0.01	-6.87	-0.08	-0.03
Other Unusual Items	1.41	1.35	0.46	1.14	0.69	8.48
Pretax Income	45.12	37.43	40.97	-95.05	34.94	47.65
Income Tax Expense	-2.84	0.13	2.05	-10.85	0.65	5.6
Earnings From Continuing Operations	47.96	37.3	38.92	-84.2	34.29	42.05
Minority Interest in Earnings	3.35	2	0.19	0.89	0.19	1.1
Net Income	51.31	39.3	39.12	-83.31	34.48	43.14
Net Income to Common	51.31	39.3	39.12	-83.31	34.48	43.14
Net Income Growth	90.54%	0.46%	-	-	-20.08%	4.63%
Shares Outstanding (Basic)	260	262	261	260	265	240
Shares Outstanding (Diluted)	260	262	261	260	265	240
Shares Change (YoY)	-1.29%	0.46%	0.17%	-1.85%	10.66%	7.94%
EPS (Basic)	0.20	0.15	0.15	-0.32	0.13	0.18
EPS (Diluted)	0.20	0.15	0.15	-0.32	0.13	0.18
EPS Growth	93.03%	-	-	-	-27.78%	-3.07%
Free Cash Flow	65.02	-37.95	58.51	-126.31	-94.38	-131.01
Free Cash Flow Per Share	0.25	-0.14	0.22	-0.48	-0.36	-0.55
Dividend Per Share	0.025	0.025	0.030	-	0.020	0.025
Dividend Growth	-16.67%	-16.67%	-	-	-20.00%	-11.03%
Gross Margin	49.52%	46.28%	38.47%	19.87%	34.14%	42.48%
Operating Margin	12.61%	7.31%	5.95%	-27.08%	5.03%	7.81%
Profit Margin	12.67%	9.68%	8.91%	-23.12%	7.43%	9.49%
Free Cash Flow Margin	16.05%	-9.35%	13.32%	-35.05%	-20.33%	-28.81%
EBITDA	46.82	40.47	57	-68.87	41.22	48.77
EBITDA Margin	11.55%	9.97%	12.98%	-19.11%	8.88%	10.73%
D&A For EBITDA	-4.26	10.8	30.86	28.7	17.86	13.27
EBIT	51.07	29.67	26.14	-97.56	23.35	35.51
EBIT Margin	12.61%	7.31%	5.95%	-27.08%	5.03%	7.81%
Effective Tax Rate	-	0.34%	5.00%	-	1.86%	11.76%
Revenue as Reported	405.15	406.01	439.25	360.33	464.2	454.74
Advertising Expenses	-	-	-	-	1.01	2.57

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.